Join
Live feed
·
PRReleasevia Quantisnow
SELLAS Life Sciences Group Inc. logo

SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference

ByQuantisnow·Wall Street's wire, on your screen.
SLS· SELLAS Life Sciences Group Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SLS (SELLAS Life Sciences Group Inc.) and more on Quantisnow.